Companies: 10,795·Total market cap: $144.5T
IntelGenx Technologies Corp.

IntelGenx Technologies Corp.

IGXTOTCHealthcare
$0.17
+$0.00(+0.00%)
Market Cap$29691860
P/E Ratio
52W High$0.17
52W Low$0.1593
Overview

IntelGenx Technologies Corp.(IGXT)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · IGXT · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.06igxt eps ttm · igxt earnings per shareEarnings history
PE Ratio (TTM)igxt pe ratio ttm · igxt price to earningsPE Ratio deep dive
Revenue (TTM)$1.1Migxt revenue ttm · igxt annual revenueFull revenue history
Dividend Yield不分红does igxt pay dividends · igxt dividend yieldDividend history
Shares Outstanding174.7Migxt shares outstanding · igxt floatShares outstanding history
Next EarningsTBAigxt earnings date · igxt next earningsEarnings history

财务快照

完整财报
FY 2023Revenue$1.0M▲ +9.37% YoY
202120222023
intelgenx technologies corp. revenue · igxt revenue 2023
FY 2023Net Income-$9.9M▲ +17.05% YoY
202120222023
intelgenx technologies corp. net income · igxt profit 2023
FY 2023EPS$-0.06▲ +21.76% YoY
202120222023
igxt eps · intelgenx technologies corp. earnings per share 2023
TTM:Revenue: $1.1MNet Income: -$11.0MEPS: $-0.06View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy2 位分析师is igxt a buy · igxt analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.17Current
$Avg Target
$High
igxt price target · igxt 12 month forecast

合计: 2 · 买入占比: 100.0%

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-20.54%

关于 IntelGenx Technologies Corp.

CEOTommy Kenny
IPO DateJan 17, 2007
Employees48
CountryCA

IntelGenx Technologies Corp. a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatripta…

what is intelgenx technologies corp. · igxt stock overview · intelgenx technologies corp. company profile · who is intelgenx technologies corp. ceo · igxt OTC · intelgenx technologies corp. headquarters · intelgenx technologies corp. business segments

关于股票概览与关键数据

IntelGenx Technologies Corp.(IGXT)是 Biotechnology 行业的 Healthcare 类公司,于 Jan 17, 2007 在 OTC 上市。截至最近交易日,IGXT 股价为 $0.17,市值约为 $29.7M。过去12个月累计回报 +0.00%,年初至今回报 +0.00%。

根据 2 位华尔街分析师,IntelGenx Technologies Corp. 股票共识评级为Buy,12个月平均目标价为 $—。2023 财年 IntelGenx Technologies Corp. 营收 $1.0M,净利润 -$9.9M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,IntelGenx Technologies Corp.(IGXT)股价为 $0.17,在 OTC 上市,52周区间为 $0.16 – $0.17。

IGXT 最新股价IGXT quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议